Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jul. 31, 2023	Jan. 31, 2023
Current assets
Cash and cash equivalents	$ 1,093,898	$ 1,402,119
Restricted cash	400	0
Marketable securities	735,670	354,774
Accounts receivable, net of allowance for credit losses of $1,128 and $2,698, respectively	226,327	374,217
Contract assets	80,602	69,260
Deferred contract acquisition costs	59,326	49,887
Prepaid expenses and other current assets	107,373	94,150
Total current assets	2,303,596	2,344,407
Marketable securities, non-current	0	2,942
Contract assets, non-current	5,021	6,523
Deferred contract acquisition costs, non-current	134,021	137,616
Property and equipment, net	24,679	29,045
Operating lease right-of-use assets	52,847	52,052
Intangible assets, net	19,244	23,010
Goodwill	90,051	88,010
Deferred tax asset	5,573	5,895
Other assets, non-current	35,108	45,706
Total assets	2,670,140	2,735,206
Current liabilities
Accounts payable	1,887	8,891
Accrued expenses and other current liabilities	64,404	76,645
Accrued compensation and employee benefits	67,836	142,582
Deferred revenue	384,015	398,334
Total current liabilities	518,142	626,452
Deferred revenue, non-current	103,780	121,697
Operating lease liabilities, non-current	56,699	56,442
Other liabilities, non-current	8,153	10,457
Total liabilities	686,774	815,048
Commitments and contingencies (Note 11)
Stockholders' equity
Preferred stock, $0.00001 par value per share, 20,000 shares authorized as of July 31, 2023 and January 31, 2023; 0 shares issued and outstanding as of July 31, 2023 and January 31, 2023	0	0
Additional paid-in capital	3,888,414	3,736,838
Accumulated other comprehensive income	11,506	7,612
Accumulated deficit	(1,916,560)	(1,824,298)
Total stockholders’ equity	1,983,366	1,920,158
Total liabilities and stockholders’ equity	2,670,140	2,735,206
Class A Common Stock
Stockholders' equity
Common stock	5	5
Class B Common Stock
Stockholders' equity
Common stock	$ 1	$ 1